SCHEMBL170598

SCHEMBL170598

[Ru]C1=CC=CC1.c1ccc2c(c1)[nH]c1c3cccnc3ccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDO2 P48775 4/20 0.42
KDM4E B2RXH2 4/20 0.42
MAPT P10636 4/20 0.42
GABRA1 P14867 3/20 0.42
GABRG2 P18507 3/20 0.42
GABRB3 P28472 3/20 0.42
GABRA5 P31644 3/20 0.42
GABRA3 P34903 3/20 0.42
GABRA2 P47869 3/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
GABRP O00591 2/20 0.42
GABRD O14764 2/20 0.42
GABRB1 P18505 2/20 0.42
GABRB2 P47870 2/20 0.42
GABRA4 P48169 2/20 0.42
GABRE P78334 2/20 0.42
GABRA6 Q16445 2/20 0.42
GABRG1 Q8N1C3 2/20 0.42
GABRG3 Q99928 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL458963 0.83 KIF11 (0.55) TDO2KDM4EMAPTGABRA1GABRG2
SCHEMBL29832015 0.83 KIF11 (0.55) TDO2KDM4EMAPTGABRA1GABRG2
SCHEMBL27842256 0.82 KIF11 (0.45) TDO2KDM4EMAPTGABRA1GABRG2
SCHEMBL27884581 0.81 KIF11 (0.44) TDO2KDM4EMAPTGABRA1GABRG2
SCHEMBL25298405 0.78 KDM4E (0.55) TDO2KDM4EMAPTGABRA1GABRG2
SCHEMBL31682284 0.78 KDM4E (0.55) TDO2KDM4EMAPTGABRA1GABRG2
SCHEMBL21382671 0.77 KIF11 (0.43) TDO2KDM4EMAPTGABRA1GABRG2
SCHEMBL28533079 0.76 TDO2 (0.40) TDO2KDM4EMAPTGABRA1GABRG2
Carbazole SCHEMBL170597 0.75 ALDH1A1 (0.42) TDO2KDM4EMAPTGABRA1GABRG2
SCHEMBL26675637 0.70 PARP1 (0.51) KDM4EMAPTGABRA1GABRG2GABRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 251 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10294457-B2 Maturation of hepatocyte-like cells derived from human pluripotent stem cells TAKARA BIO EUROPE AB (SE) 2019-05-21 US claimed
US-20170189496-A1 USE OF PHOSPHORYLATION PATHWAY-RELATED FACTOR IN REGULATING FUNCTION OF REGULATORY T CELL INSTITUT PASTEUR OF SHANGHAI, CHINESE ACADEMY OF SCIENCES (CN) 2017-07-06 US claimed
EP-2550355-B1 DIRECTED DIFFERENTIATION AND MATURATION OF PLURIPOTENT CELLS INTO HEPATOCYTE LIKE CELLS BY MODULATION OF WNT-SIGNALLING PATHWAY TAKARA BIO EUROP AB (SE) 2016-11-16 EP claimed
US-20160237405-A1 DIFFERENTIATION OF HUMAN PLURIPOTENT STEM CELLS TO MULTIPOTENT NEURAL CREST CELLS UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. 2016-08-18 US claimed
US-9394522-B2 Directed differentiation and maturation of pluripotent cells into hepatocyte like cells by modulation of Wnt-signalling pathway TAKARA BIO EUROPE AB (SE) 2016-07-19 US claimed
CN-105143445-A Maturation of hepatocyte-like cells derived from human pluripotent stem cells TAKARA BIO EUROP AB 2015-12-09 CN claimed
US-9175260-B2 Early mesoderm cells, a stable population of mesendoderm cells that has utility for generation of endoderm and mesoderm lineages and multipotent migratory cells (MMC) TheUniversity of Georgia Research Foundation, Inc. (US) 2015-11-03 US claimed
US-20150307839-A1 MATURATION OF HEPATOCYTE-LIKE CELLS DERIVED FROM HUMAN PLURIPOTENT STEM CELLS TAKARA BIO EUROPE AB (SE) 2015-10-29 US claimed
EP-2925859-A1 MATURATION OF HEPATOCYTE-LIKE CELLS DERIVED FROM HUMAN PLURIPOTENT STEM CELLS Takara Bio Europe AB (SE) 2015-10-07 EP claimed
US-20150073043-A1 USE OF PHOSPHORYLATION PATHWAY-RELATED FACTOR IN REGULATING FUNCTION OF REGULATORY T CELL INSTITUT PASTEUR OF SHANGHAI, CHINESE ACADEMY OF SCIENCES (CN) 2015-03-12 US claimed
WO-2014083132-A1 MATURATION OF HEPATOCYTE-LIKE CELLS DERIVED FROM HUMAN PLURIPOTENT STEM CELLS CELLECTIS SA (FR) 2014-06-05 WO claimed
CN-103627671-A Method for generating endoderm and mesoderm lineages and multipotent migratory cells (MMC), and cell population and use UNIV GEORGIA 2014-03-12 CN claimed
US-20130095567-A1 DIRECTED DIFFERENTIATION AND MATURATION OF PLURIPOTENT CELLS INTO HEPATOCYTE LIKE CELLS BY MODULATION OF WNT-SIGNALLING PATHWAY CELLARTIS AB (SE) 2013-04-18 US claimed
EP-2550355-A1 DIRECTED DIFFERENTIATION AND MATURATION OF PLURIPOTENT CELLS INTO HEPATOCYTE LIKE CELLS BY MODULATION OF WNT-SIGNALLING PATHWAY Cellartis AB (SE) 2013-01-30 EP claimed
WO-2011116930-A1 DIRECTED DIFFERENTIATION AND MATURATION OF PLURIPOTENT CELLS INTO HEPATOCYTE LIKE CELLS BY MODULATION OF WNT-SIGNALLING PATHWAY CELLARTIS AB (SE) 2011-09-29 WO claimed
WO-2010108005-A2 NOVEL NEURAL PROGENITORS FROM PLURIPOTENT STEM CELLS, METHODS OF PRODUCING SAME AND USE TO PRODUCE NEURAL CELLS UNIVERSITY OF GEORGIA RESEARCH FOUNDATION (US) 2010-09-23 WO claimed
US-20100166713-A1 EARLY MESODERM CELLS, A STABLE POPULATION OF MESENDODERM CELLS THAT HAS UTILITY FOR GENERATION OF ENDODERM AND MESODERM LINEAGES AND MULTIPOTENT MIGRATORY CELLS (MMC) THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. 2010-07-01 US claimed
CN-101641436-A Early mesodermal cells, a stable population of mesendodermal cells, for use in the production of endodermal and mesodermal cell lines and Multipotent Migratory Cells (MMCs) UNIV GEORGIA RES FOUND US 2010-02-03 CN claimed
EP-2126045-A2 EARLY MESODERM CELLS, A STABLE POPULATION OF MESENDODERM CELLS THAT HAS UTILITY FOR GENERATION OF ENDODERM AND MESODERM LINEAGES AND MULTIPOTENT MIGRATORY CELLS (MMC) UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2009-12-02 EP claimed
WO-2008094597-A2 EARLY MESODERM CELLS, A STABLE POPULATION OF MESENDODERM CELLS THAT HAS UTILITY FOR GENERATION OF ENDODERM AND MESODERM LINEAGES AND MULTIPOTENT MIGRATORY CELLS (MMC) UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2008-08-07 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170189496-A1 USE OF PHOSPHORYLATION PATHWAY-RELATED FACTOR IN REGULATING FUNCTION OF REGULATORY T CELL NFATC1, PIM1, PIM2 TDO2 2596/4885KDM4E 2018/4885MAPT 3988/4885
US-20150073043-A1 USE OF PHOSPHORYLATION PATHWAY-RELATED FACTOR IN REGULATING FUNCTION OF REGULATORY T CELL NFATC1, PIM1, PIM2 TDO2 2596/4885KDM4E 2018/4885MAPT 3988/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.